List of Tables
Table 1. Global Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Urinalysis
Table 3. Key Players of Prostate-Specific Antigen (PSA) Blood Test
Table 4. Key Players of Urodynamic Test
Table 5. Key Players of Cystoscopy
Table 6. Global Benign Prostatic Hyperplasia Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Benign Prostatic Hyperplasia Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Benign Prostatic Hyperplasia Testing Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Benign Prostatic Hyperplasia Testing Market Share by Region (2020-2025)
Table 10. Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Benign Prostatic Hyperplasia Testing Market Share by Region (2026-2031)
Table 12. Benign Prostatic Hyperplasia Testing Market Trends
Table 13. Benign Prostatic Hyperplasia Testing Market Drivers
Table 14. Benign Prostatic Hyperplasia Testing Market Challenges
Table 15. Benign Prostatic Hyperplasia Testing Market Restraints
Table 16. Global Benign Prostatic Hyperplasia Testing Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Benign Prostatic Hyperplasia Testing Market Share by Players (2020-2025)
Table 18. Global Top Benign Prostatic Hyperplasia Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Testing as of 2024)
Table 19. Ranking of Global Top Benign Prostatic Hyperplasia Testing Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Benign Prostatic Hyperplasia Testing Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Benign Prostatic Hyperplasia Testing, Headquarters and Area Served
Table 22. Global Key Players of Benign Prostatic Hyperplasia Testing, Product and Application
Table 23. Global Key Players of Benign Prostatic Hyperplasia Testing, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Benign Prostatic Hyperplasia Testing Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Type (2020-2025)
Table 27. Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Type (2026-2031)
Table 29. Global Benign Prostatic Hyperplasia Testing Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Application (2020-2025)
Table 31. Global Benign Prostatic Hyperplasia Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Benign Prostatic Hyperplasia Testing Revenue Market Share by Application (2026-2031)
Table 33. North America Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Benign Prostatic Hyperplasia Testing Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Benign Prostatic Hyperplasia Testing Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Benign Prostatic Hyperplasia Testing Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Benign Prostatic Hyperplasia Testing Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Benign Prostatic Hyperplasia Testing Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Benign Prostatic Hyperplasia Testing Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size by Country (2026-2031) & (US$ Million)
Table 48. AEternaZentaris Company Details
Table 49. AEternaZentaris Business Overview
Table 50. AEternaZentaris Benign Prostatic Hyperplasia Testing Product
Table 51. AEternaZentaris Revenue in Benign Prostatic Hyperplasia Testing Business (2020-2025) & (US$ Million)
Table 52. AEternaZentaris Recent Development
Table 53. Astellas Pharma Company Details
Table 54. Astellas Pharma Business Overview
Table 55. Astellas Pharma Benign Prostatic Hyperplasia Testing Product
Table 56. Astellas Pharma Revenue in Benign Prostatic Hyperplasia Testing Business (2020-2025) & (US$ Million)
Table 57. Astellas Pharma Recent Development
Table 58. Eli Lilly and Company Company Details
Table 59. Eli Lilly and Company Business Overview
Table 60. Eli Lilly and Company Benign Prostatic Hyperplasia Testing Product
Table 61. Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Testing Business (2020-2025) & (US$ Million)
Table 62. Eli Lilly and Company Recent Development
Table 63. IntelGenx Technologies Corp Company Details
Table 64. IntelGenx Technologies Corp Business Overview
Table 65. IntelGenx Technologies Corp Benign Prostatic Hyperplasia Testing Product
Table 66. IntelGenx Technologies Corp Revenue in Benign Prostatic Hyperplasia Testing Business (2020-2025) & (US$ Million)
Table 67. IntelGenx Technologies Corp Recent Development
Table 68. Nymox Pharmaceutical Corporation Company Details
Table 69. Nymox Pharmaceutical Corporation Business Overview
Table 70. Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Testing Product
Table 71. Nymox Pharmaceutical Corporation Revenue in Benign Prostatic Hyperplasia Testing Business (2020-2025) & (US$ Million)
Table 72. Nymox Pharmaceutical Corporation Recent Development
Table 73. Protox Therapeutics Company Details
Table 74. Protox Therapeutics Business Overview
Table 75. Protox Therapeutics Benign Prostatic Hyperplasia Testing Product
Table 76. Protox Therapeutics Revenue in Benign Prostatic Hyperplasia Testing Business (2020-2025) & (US$ Million)
Table 77. Protox Therapeutics Recent Development
Table 78. Quest PharmaTech Company Details
Table 79. Quest PharmaTech Business Overview
Table 80. Quest PharmaTech Benign Prostatic Hyperplasia Testing Product
Table 81. Quest PharmaTech Revenue in Benign Prostatic Hyperplasia Testing Business (2020-2025) & (US$ Million)
Table 82. Quest PharmaTech Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 86. Authors List of This Report
List of Figures
Figure 1. Benign Prostatic Hyperplasia Testing Picture
Figure 2. Global Benign Prostatic Hyperplasia Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Benign Prostatic Hyperplasia Testing Market Share by Type: 2024 VS 2031
Figure 4. Urinalysis Features
Figure 5. Prostate-Specific Antigen (PSA) Blood Test Features
Figure 6. Urodynamic Test Features
Figure 7. Cystoscopy Features
Figure 8. Global Benign Prostatic Hyperplasia Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Benign Prostatic Hyperplasia Testing Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Diagnostic Centers Case Studies
Figure 12. Clinics Case Studies
Figure 13. Research Institutes Case Studies
Figure 14. Benign Prostatic Hyperplasia Testing Report Years Considered
Figure 15. Global Benign Prostatic Hyperplasia Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Benign Prostatic Hyperplasia Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Benign Prostatic Hyperplasia Testing Market Share by Region: 2024 VS 2031
Figure 18. Global Benign Prostatic Hyperplasia Testing Market Share by Players in 2024
Figure 19. Global Top Benign Prostatic Hyperplasia Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Testing as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Benign Prostatic Hyperplasia Testing Revenue in 2024
Figure 21. North America Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Benign Prostatic Hyperplasia Testing Market Share by Country (2020-2031)
Figure 23. United States Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Benign Prostatic Hyperplasia Testing Market Share by Country (2020-2031)
Figure 27. Germany Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Benign Prostatic Hyperplasia Testing Market Share by Region (2020-2031)
Figure 35. China Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Benign Prostatic Hyperplasia Testing Market Share by Country (2020-2031)
Figure 43. Mexico Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Benign Prostatic Hyperplasia Testing Market Share by Country (2020-2031)
Figure 47. Turkey Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Benign Prostatic Hyperplasia Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. AEternaZentaris Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2020-2025)
Figure 51. Astellas Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2020-2025)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2020-2025)
Figure 53. IntelGenx Technologies Corp Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2020-2025)
Figure 54. Nymox Pharmaceutical Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2020-2025)
Figure 55. Protox Therapeutics Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2020-2025)
Figure 56. Quest PharmaTech Revenue Growth Rate in Benign Prostatic Hyperplasia Testing Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
